Related Experiment Video
Updated: Aug 10, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long Non-Coding RNAs as Novel Targets for Phytochemicals to Cease Cancer Metastasis
Sadegh Rajabi1, Huda Fatima Rajani2, Niloufar Mohammadkhani3
1Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1434875451, Iran.
This review explores how long non-coding RNAs (LncRNAs) drive cancer metastasis and how plant-derived phytochemicals can target these molecules to inhibit cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Metastasis is a critical, multi-step process in cancer progression, responsible for over 90% of cancer-related deaths globally.
- Long non-coding RNAs (LncRNAs) are key regulators of gene expression, influencing various cancer development stages, including metastasis.
- Emerging evidence highlights the significant role of LncRNAs in the metastatic potential of diverse cancers.
Purpose of the Study:
- To elucidate the steps involved in cancer metastasis.
- To review established LncRNAs implicated in the metastatic cascade.
- To identify phytochemical compounds that target LncRNAs to suppress cancer metastasis.
Main Methods:
- Literature review of metastasis mechanisms.
- Analysis of scientific data on LncRNAs involved in cancer spread.
- Identification of phytochemicals with anti-metastatic properties targeting LncRNAs.
Main Results:
- Detailed description of the multi-step metastatic process.
- Summary of key LncRNAs that promote or inhibit cancer metastasis.
- Catalog of phytochemicals demonstrated to interfere with LncRNA function in metastasis.
Conclusions:
- LncRNAs are crucial mediators of cancer metastasis.
- Phytochemicals represent a promising therapeutic strategy for targeting LncRNAs to combat metastatic cancer.
- Further research into LncRNA-phytochemical interactions could lead to novel anti-cancer treatments.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
lncRNA - Long Non-coding RNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
MicroRNAs
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Non-Canonical Wnt Signaling Pathways